The Supreme Court has declined to dismiss Rhea Chakraborty’s case against Sushant Singh Rajput’s sister; the CBI will investigate.
On Friday, the Supreme Court ruled that actor Rhea Chakraborty’s case against Sushant Singh Rajput’s sister Priyanka Singh will not be dismissed. Chakraborty accused Priyanka of arranging a forged prescription to give Sushant access to forbidden drugs.
The CBI will now take over the case and prosecute it, as the Supreme Court previously directed that all FIRs linked to Sushant’s death be handled by the central investigation agency.
Actress Rhea Chakraborty, who is being investigated by several federal agencies after Sushant Singh Rajput’s family accused her of being involved in the actor’s murder, has lodged a complaint against Rajput’s sisters Priyanka and Mitu Singh. Based on Chakraborty’s complaint, the sisters were charged with forgery and breaching the NDPS (Narcotic Drugs and Psychotropic Substances) Act.
On June 8, six days before his death, Actress Rhea Chakraborty lodged a complaint based on Whatsapp texts exchanged between Sushant and Priyanka Singh. Priyanka told her brother to take three medications: Librium, Mexito, and Lonazep, according to the conversation. They are used for depression and anxiety but cannot be purchased off the counter and must be obtained via a prescription.
On February 15, the Bombay High Court ordered that the inquiry into Priyanka Singh be continued while the case against Mitu Singh be dismissed. Priyanka’s counsel pleaded in the Supreme Court on Friday that there was no proof of Sushant drinking the alleged drug. In her petition, she also claimed that the doctor she visited was eligible to administer the medications and that she did so through teleconsultation.